Form 4: Insmed CFO Sara Bonstein Sells Shares Under 10b5-1 Trading Plan

Sara Bonstein, CFO of Insmed Inc., sold shares of common stock on February 11 and 12, 2025, according to a Form 4 filing with the SEC.

Summary

• Sara Bonstein, the Chief Financial Officer of Insmed Inc., reported the sale of company stock in a Form 4 filing with the SEC.
• The transactions occurred on February 11 and February 12, 2025.
• On February 11, 2025, Ms. Bonstein sold 13,302 shares of Insmed common stock at a price of $80 per share.
• On February 12, 2025, she sold an additional 5,019 shares at $80 per share.
• Following these transactions, Ms. Bonstein directly owns 137,185 shares of Insmed common stock.
• The sales were executed under a pre-arranged 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the stock sales were conducted under a pre-arranged 10b5-1 trading plan, which is a common practice. It doesn't necessarily indicate a positive or negative outlook on the company's future.

Industry Context

Sales by company insiders are a common occurrence and are often pre-planned through 10b5-1 trading plans to avoid accusations of trading on material non-public information. The market typically analyzes the size and frequency of such sales to gauge insider sentiment.

Stakeholder Impact

• Shareholders may be interested in insider trading activity as an indicator of management's confidence in the company.
• Employees may be interested in insider trading activity as an indicator of the company's future prospects.

Key Dates